[go: up one dir, main page]

FR3127693B1 - TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID - Google Patents

TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID Download PDF

Info

Publication number
FR3127693B1
FR3127693B1 FR2110524A FR2110524A FR3127693B1 FR 3127693 B1 FR3127693 B1 FR 3127693B1 FR 2110524 A FR2110524 A FR 2110524A FR 2110524 A FR2110524 A FR 2110524A FR 3127693 B1 FR3127693 B1 FR 3127693B1
Authority
FR
France
Prior art keywords
composition
weight
transparent
polyhydroxy
polyhydroxyacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2110524A
Other languages
French (fr)
Other versions
FR3127693A1 (en
Inventor
Wei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2110524A priority Critical patent/FR3127693B1/en
Priority to KR1020247006144A priority patent/KR20240036662A/en
Priority to PCT/JP2022/032303 priority patent/WO2023032869A1/en
Priority to EP22769792.7A priority patent/EP4395735A1/en
Priority to US18/685,385 priority patent/US20240423892A1/en
Publication of FR3127693A1 publication Critical patent/FR3127693A1/en
Application granted granted Critical
Publication of FR3127693B1 publication Critical patent/FR3127693B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSITION TRANSPARENTE COMPRENANT UN POLYHYDROXY ACIDE La présente invention concerne une composition transparente comprenant : (a) au moins un premier composé choisi parmi les polyhydroxyacides et leurs sels ; (b) au moins un second composé choisi parmi la vitamine B3 et ses dérivés ; (c) au moins un dérivé d’oxyde d’alkylène représenté par une formule chimique spécifique ; et (d) de l’eau, dans laquelle la quantité du ou des (a) premier(s) composé(s) dans la composition est de 1 % en poids ou plus, de préférence de 3 % en poids ou plus, et de manière davantage préférée de 5 % en poids ou plus, par rapport au poids total de la composition. La composition selon la présente invention est transparente, et peut assurer moins de caractère collant et un inconfort de la peau réduit tel qu’une irritation de la peau réduite, lorsque la composition est appliquée sur la peau, bien que la composition inclue une quantité relativement importante de polyhydroxyacide ou de sel de celui-ci Figure pour l’abrégé : NEANTTRANSPARENT COMPOSITION COMPRISING AN ACIDIC POLYHYDROXY The present invention relates to a transparent composition comprising: (a) at least one first compound chosen from polyhydroxy acids and their salts; (b) at least one second compound chosen from vitamin B3 and its derivatives; (c) at least one alkylene oxide derivative represented by a specific chemical formula; and (d) water, wherein the amount of the first compound(s) in the composition is 1% by weight or more, preferably 3% by weight or more, and more preferably 5% by weight or more, based on the total weight of the composition. The composition according to the present invention is transparent, and can provide less stickiness and reduced skin discomfort such as reduced skin irritation, when the composition is applied to the skin, although the composition includes a relatively significant amount of polyhydroxy acid or salt thereof Figure for abstract: NIL

FR2110524A 2021-08-30 2021-10-05 TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID Active FR3127693B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR2110524A FR3127693B1 (en) 2021-10-05 2021-10-05 TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID
KR1020247006144A KR20240036662A (en) 2021-08-30 2022-08-23 Transparent composition comprising polyhydroxy acid
PCT/JP2022/032303 WO2023032869A1 (en) 2021-08-30 2022-08-23 Transparent composition comprising polyhydroxy acid
EP22769792.7A EP4395735A1 (en) 2021-08-30 2022-08-23 Transparent composition comprising polyhydroxy acid
US18/685,385 US20240423892A1 (en) 2021-08-30 2022-08-23 Transparent composition comprising polyhydroxy acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2110524A FR3127693B1 (en) 2021-10-05 2021-10-05 TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID
FR2110524 2021-10-05

Publications (2)

Publication Number Publication Date
FR3127693A1 FR3127693A1 (en) 2023-04-07
FR3127693B1 true FR3127693B1 (en) 2024-03-15

Family

ID=78483397

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2110524A Active FR3127693B1 (en) 2021-08-30 2021-10-05 TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID

Country Status (1)

Country Link
FR (1) FR3127693B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3148144A1 (en) * 2023-04-27 2024-11-01 L'oreal BIPHASIC COMPOSITION AND ITS PROCESSES
WO2025102195A1 (en) * 2023-11-13 2025-05-22 L'oreal Composition for caring for keratin materials
FR3158647A1 (en) * 2024-01-31 2025-08-01 L'oreal Composition comprising at least one extract of a plant of the Fagaceae family, at least two α-hydroxy acids, at least one β-hydroxy acid or its derivatives and at least one phosphonic derivative
WO2025170081A1 (en) * 2024-02-05 2025-08-14 L'oreal Stabilization of composition comprising polyhydroxy acid, beta-hydroxy acid and peptide with polyol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364633A (en) 1994-03-14 1994-11-15 Dow Corning Corporation Silicone vesicles and entrapment
WO2013158824A2 (en) * 2012-04-19 2013-10-24 The Procter & Gamble Company Cosmetic compositions
CN109730949A (en) * 2019-03-04 2019-05-10 广州市华晟健康产业有限公司 It is a kind of with crease-resistant compact effect Medical-use cold compress pad pasting
KR102212787B1 (en) * 2020-10-15 2021-02-08 (주)제이에이치사이언스 Peeling composition for skin whitening

Also Published As

Publication number Publication date
FR3127693A1 (en) 2023-04-07

Similar Documents

Publication Publication Date Title
FR3127693B1 (en) TRANSPARENT COMPOSITION COMPRISING A POLYHYDROXYACID
US4959393A (en) Skin depigmental agent
CA2191129C (en) Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
JPH0713009B2 (en) Toothpaste composition
EP0316993B1 (en) Pharmaceutical compositions containing a derivative of 3-hydroxy-butanoic acid chosen among oligomers of this acid and among esters of this acid or of these oligomers with 1,3-butane-diol
EP0755925B1 (en) N,N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene-diamine derivatives and their use in pharmaceutical and cosmetic compositions
EP0623339A1 (en) Use of 4-,4- and 5-, or 4- and 6-substituted derivatives of resorcin in cosmetic or dermopharmaceutical compositions for depigmentation
FR2608045A1 (en) USE OF XANTHINE OXIDASE INHIBITORS, OXYGEN FREE RADIAL TRAPERS AND IRON CHELATORS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA
EP0826657B1 (en) Compounds for modulation of hormone receptors, compositions containing them and their use in therapy
EP0623341A1 (en) Use of 4-thioresorcin derivatives in skin whitening cosmetic or dermopharmaceutical compositions
EP0087378B1 (en) Oxime-ethers of alkylamino alcohols as medicaments, compounds and process for their preparation
FR2526313A1 (en) COMPOSITIONS SOLAR SCREENS
CN1273239A (en) (Poly) thia acetylenic acid and it derivative, composite containing them and its application
EP0755917B1 (en) N,N'-di(aralkyl) N,N'-di(carboxyalkyl) alkylen- diamino-derivatives, N-(aralkyl) N'-(carboxyalkyl) N,N'-di(carboxyalkyl) alkylen- diamino-derivatives and N,N"-di(aralkyl)N,N',N"-tri(carboxyalkyl)dialkylen triamino derivatives and their use in pharmacy and cosmetics
FR2447189A1 (en) NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING AS ACTIVE INGREDIENTS OF ALKYLENE-DITHIOETHERS
FR2542614A1 (en) PHARMACEUTICAL COMPOSITIONS WITH ANTI-NEOPLASTIC ACTIVITY, COMPRISING A SELENIUM COMPOUND AND A CARBOXYLIC ACID, AN ALDEHYDE OR KETONE
JPH0132805B2 (en)
FR3121356B1 (en) Composition for the care of keratinous materials
US4933362A (en) Sunburn treatment composition
EP1227791B1 (en) Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
EP0524108B1 (en) Use of derivatives of benzofurane as depigmentation agents in cosmetic or dermatological compositions
JPS59128320A (en) Lightening cosmetic
EP0304649B1 (en) Salts of 6-piperidino-2,4-diaminopyrimidin-3-oxide and of derivatives of thiamorpholin-3-on-5-carboxylic acid, their cosmetical and medicinal use.
CH622181A5 (en) Make-up removal lotion for the eyes
US4746738A (en) Tetrahydro-1,3-thiazin-2,4-dione derivatives

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230407

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4